JACOB AJA: Open Payments
NPI 1073794012 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$459 in 17 payments from 7 companies in 2025. Trend: 2023 $946 · 2024 $1,487 · 2025 $459
Food & beverage: $362Education: $97
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $97 |
| SANOFI-AVENTIS U.S. LLC | 1 | $97 |
| PFIZER INC. | 4 | $90 |
| Organon LLC | 3 | $62 |
| Novartis Pharmaceuticals Corporation | 2 | $54 |
| UCB, Inc. | 2 | $42 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: SKYRIZI, DUPIXENT, VTAMA, EUCRISA, CIBINQO, Bimzelx, Rhapsido, COSENTYX.
Industry payments across MD — which companies pay providers there.
